Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstract
Abstract Fertivision 2017
Case Report
Clinical Practice Guideline
Commentary
Current Issue
Editor's view point
Editorial
Editorial View Point
Fertivision 2015 - Abstracts
Guest Editorial
IFS pages
Letter to the Editor
Original Article
Original Research
PCOS Guideline
Point of View
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstract
Abstract Fertivision 2017
Case Report
Clinical Practice Guideline
Commentary
Current Issue
Editor's view point
Editorial
Editorial View Point
Fertivision 2015 - Abstracts
Guest Editorial
IFS pages
Letter to the Editor
Original Article
Original Research
PCOS Guideline
Point of View
Review Article
View/Download PDF

Translate this page into:

Commentary
2 (
2
); 161-162
doi:
10.4103/2394-4285.196792

Immunomodulation at the receptor-mediated cell-signalling, molecular level for fertility treatment

Sr. Consultant, Reproductive medicine & IVF, Medicover Fertility, Delhi, India

Address for correspondence: Dr. Sweta Gupta, MBBS, MD (Obs & Gynae, Delhi), MRCOG (London, UK), DFSRH (UK), MSc (Reproduction & Development, UK), Fellowship in Reproductive medicine & ART (London, UK), Clinical Director and Sr. Consultant, Reproductive Medicine & IVF, A-12, Sector 35, Noida, India. E-mail: swetagupta06@yahoo.com

Read COMMENTARY-ARTICLE associated with this -

Licence

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.

An increase in incidence of infertility has been seen in recent times. Infertility is often associated with significant psychological stress to the couple. Unfortunately, success rate of fertility treatment has not improved dramatically. Targeting biochemical-signalling pathways at the molecular and cellular level is emerging as a treatment strategy, wherein focussed research is required. Individualized immunotherapeutic treatment strategies by targeted manipulation of Toll-like receptor (TLR) signalling regulatory network could be quite promising to improve the success rate of fertility treatment.

TLRs[1] are a class of proteins that play a key role in the innate immune system. They are single, membrane-spanning, non-catalytic receptors usually expressed as macrophages and dendritic cells, which recognize structurally conserved molecules derived from microbes. TLRs are now counted among the key molecules that alert the immune system to the presence of microbial infections. They were named so in 1985 because of their similarity to the protein coded by the toll gene identified in Drosophila. Female reproductive tract is in close contact with allogenic sperms and transmitted microorganisms during intercourse and with semi-allogenic foetus during pregnancy.[2] Zandieh et al.[3] described TLRs as one of the main components of the innate immune system.

Poor ovarian response (POR) to gonadotropin stimulation has led to a significant decline in the success rate of fertility treatment. The immune system may play an important role in pathophysiology of POR by dysfunctions of cytokines and the growth factor network, and the presence of ovarian auto-antibodies.[4] Taghavi et al.[4] investigated the expression of Toll-like receptors and cyclooxygenase (COX) 2 genes in follicular cells and concentration of interleukin and macrophage migration inhibitory factor, as major parts of innate immunity, in follicular fluid obtained from POR women in comparison with normal women. TLR and COX2 gene expression were found to be significantly higher in POR. Toll-like receptor 2 (TLR2) and interferon-gamma (IFN-γ) coordinate with a diverse array of cellular programs through the transcriptional regulation of immunologically relevant genes and play an important role in immune system, reproductive physiology and basic pathology. Alterations in the functions of TLR2, IFN-γ and signalling molecules that result from polymorphisms are often associated with susceptibility or resistance, which may, in turn, establish the innate host response to the various infectious diseases.[5]

There are different areas in infertility wherein receptor-based cell signalling could be primarily responsible for reproductive disorders like oocyte maturation, sperm function, pre-embryo morphology, genital infections, impaired endometrial implantation, etc. Molecular biology research-oriented experimental studies are required in the future. The article "Dissecting Toll-like Receptor Molecular Regulatory Network(s) in Reproductive Medicine, Primarily Infertility: A Snapshot" is an interesting article and will encourage researchers to do further studies on this topic. Hopefully, it will be a step towards the next level of advancement by providing personalized immunotherapeutic treatment.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

REFERENCES

  1. . Female infertility: Reproduction and toll like receptors (TLRS) Int J Fertil Steril. 2011;5(Suppl 1):14-5.
    [Google Scholar]
  2. , , , , , . The effect of estradiol and progesterone on Toll like receptor gene expression in a human fallopian tube epithelial cell line. Cell J. 2016;17:678-91.
    [Google Scholar]
  3. , , , , , . Toll-like receptors expression in follicular cells of patients with poor ovarian response. Int J Fertil Steril. 2014;8:183-92.
    [Google Scholar]
  4. , , , , , . Investigation of Toll-like receptor-2 (2258G/A) and interferon gamma (+874T/A) gene polymorphisms among infertile women with female genital tuberculosis. PLoS One. 2015;10(6):e0130273. doi: 10.1371/journal.pone.0130273. eCollection 2015.
    [Google Scholar]
Show Sections